UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral phosphate binders

Kidney international, 2009-05, Vol.75 (9), p.906-914

Hutchison, Alastair J.

2009

Volltextzugriff (PDF)

Lanthanum carbonate: safety data after 10 years

Nephrology (Carlton, Vic.), 2016-12, Vol.21 (12), p.987-994

2016

Volltextzugriff (PDF)

Novel phosphate binders: plus ça change, plus c’est la même chose

Kidney international, 2014-09, Vol.86 (3), p.471-474

Hutchison, Alastair J.

2014

Volltextzugriff (PDF)

Lanthanum carbonate: safety data after 10years

Nephrology (Carlton, Vic.), 2016-12, Vol.21 (12), p.987-994

2016

Volltextzugriff (PDF)

Hyperphosphataemia in 2019: have we made progress?

Current opinion in nephrology and hypertension, 2019-09, Vol.28 (5), p.441-447

2019

Volltextzugriff (PDF)

Cardiovascular disease in patients with chronic kidney disease

Vascular health and risk management, 2009-01, Vol.5 (default), p.713-722

2009

Volltextzugriff (PDF)

Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trust

BMC nephrology, 2014-05, Vol.15 (1), p.84-84, Article 84

2014

Volltextzugriff (PDF)

Pharmacology, efficacy and safety of oral phosphate binders

Nature reviews. Nephrology, 2011-10, Vol.7 (10), p.578-589

2011

Volltextzugriff (PDF)

A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis

BMC nephrology, 2019-02, Vol.20 (1), p.37-37, Article 37

2019

Volltextzugriff (PDF)

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden

Nephrology, dialysis, transplantation, 2008-11, Vol.23 (11), p.3677-3684

2008

Volltextzugriff (PDF)

Renal hyperparathyroidism- a risk factor in the development of encapsulating peritoneal sclerosis

Frontiers in endocrinology (Lausanne), 2024-03, Vol.15, p.1282925-1282925

2024

Volltextzugriff (PDF)

Outcomes of peritoneal dialysis patients and switching to hemodialysis: a competing risks analysis

Peritoneal dialysis international, 2014-05, Vol.34 (3), p.289-298

2014

Volltextzugriff (PDF)

A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism

BMC nephrology, 2021-03, Vol.22 (1), p.106-106, Article 106

2021

Volltextzugriff (PDF)

Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure

Kidney international, 2005-11, Vol.68 (5), p.2381-2388

2005

Volltextzugriff (PDF)

Profiling patient attitudes to phosphate binding medication: A route to personalising treatment and adherence support

Psychology & health, 2014-01, Vol.29 (12), p.1407-1420

2014

Volltextzugriff (PDF)

Long-Term Efficacy and Safety Profile of Lanthanum Carbonate: Results for up to 6 Years of Treatment

Nephron. Clinical practice, 2008-01, Vol.110 (1), p.c15-c23

2008

Volltextzugriff (PDF)

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients

BMC nephrology, 2013-02, Vol.14 (1), p.40-40, Article 40

2013

Volltextzugriff (PDF)

Lanthanum and phosphate: science, policy, and survival

Kidney international, 2009-02, Vol.75 (4), p.355-357

Hutchison, Alastair J.

2009

Volltextzugriff (PDF)

Hyperphosphataemia in renal failure: Causes, consequences and current management

Drugs (New York, N.Y.), 2003-01, Vol.63 (6), p.577-596

2003

Volltextzugriff (PDF)

A multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients

Kidney international, 2003-06, Vol.63 (S85), p.S73-S78

2003

Volltextzugriff (PDF)

Iron-Magnesium Hydroxycarbonate (Fermagate): A Novel Non-Calcium-Containing Phosphate Binder for the Treatment of Hyperphosphatemia in Chronic Hemodialysis Patients

Clinical journal of the American Society of Nephrology, 2009-02, Vol.4 (2), p.401-409

2009

Volltextzugriff (PDF)

Proximal calciphylaxis treated with calcimimetic 'Cinacalcet'

Nephrology, dialysis, transplantation, 2008-01, Vol.23 (1), p.387-389

2008

Volltextzugriff (PDF)

Long-Term Efficacy and Tolerability of Lanthanum Carbonate: Results from a 3-Year Study

Nephron. Clinical practice, 2006-01, Vol.102 (2), p.c61-c71

2006

Volltextzugriff (PDF)

Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate

Therapeutics and clinical risk management, 2008-10, Vol.4 (5), p.887-893

2008

Volltextzugriff (PDF)

Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: a 4-week, dose-finding, open-label study with lanthanum carbonate

Nephrology, dialysis, transplantation, 2004-07, Vol.19 (7), p.1902-1906

2004

Volltextzugriff (PDF)

1 – 25 von 180

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(141)

Publikationsform

Sprache

Englisch
(180)

Erscheinungsjahr

n.n

Thema

Science & Technology
(106)
Life Sciences & Biomedicine
(103)
Humans
(88)
Urology & Nephrology
(61)
Biological And Medical Sciences
(50)
Female
(50)
Medical Sciences
(45)
Male
(44)
Middle Aged
(37)
Adult
(29)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(26)
Intensive Care Medicine
(25)
Aged
(24)
Kidney Failure, Chronic - Therapy
(21)
Emergency And Intensive Care: Renal Failure. Dialysis Management
(20)
Lanthanum - Therapeutic Use
(19)
Phosphates - Blood
(19)
Social Sciences
(18)
Animals
(17)
Kidney Failure, Chronic - Complications
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oral phosphate binders

Lanthanum carbonate: safety data after 10 years

Novel phosphate binders: plus ça change, plus c’est la même chose

Lanthanum carbonate: safety data after 10years

Hyperphosphataemia in 2019: have we made progress?

Cardiovascular disease in patients with chronic kidney disease

Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trust

Pharmacology, efficacy and safety of oral phosphate binders

A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden

Renal hyperparathyroidism- a risk factor in the development of encapsulating peritoneal sclerosis

Outcomes of peritoneal dialysis patients and switching to hemodialysis: a competing risks analysis

A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism

Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure

Profiling patient attitudes to phosphate binding medication: A route to personalising treatment and adherence support

Long-Term Efficacy and Safety Profile of Lanthanum Carbonate: Results for up to 6 Years of Treatment

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients

Lanthanum and phosphate: science, policy, and survival

Hyperphosphataemia in renal failure: Causes, consequences and current management

A multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients

Iron-Magnesium Hydroxycarbonate (Fermagate): A Novel Non-Calcium-Containing Phosphate Binder for the Treatment of Hyperphosphatemia in Chronic Hemodialysis Patients

Proximal calciphylaxis treated with calcimimetic 'Cinacalcet'

Long-Term Efficacy and Tolerability of Lanthanum Carbonate: Results from a 3-Year Study

Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate

Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: a 4-week, dose-finding, open-label study with lanthanum carbonate

Suchergebnisse filtern